Therefore, we hypothesized that harmine might be a sensitizer of AZD9291 in EGFR wild‐type NSCLC treatment by suppressing the STAT3/EGFR/Met pathway. This evidence concerns the gene STAT3 and non-small cell lung carcinoma.